Patents by Inventor Sampath Kumar Anandan

Sampath Kumar Anandan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble epoxide hydrolase inhibitors
    Publication number: 20090270382
    Abstract: Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.
    Type: Application
    Filed: April 17, 2009
    Publication date: October 29, 2009
    Inventors: Bhasker R. Aavula, Sampath-Kumar Anandan, Richard D. Gless, JR.
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
    Publication number: 20090247521
    Abstract: The present invention generally relates to methods useful for a therapy using a class of urea or amide compounds and related compositions, wherein the compound is a soluble epoxide hydrolase inhibitor, for treating and ameliorating the symptoms of diseases related to endothelial dysfunction.
    Type: Application
    Filed: December 23, 2008
    Publication date: October 1, 2009
    Inventors: Bhasker R. Aavula, Sampath-Kumar Anandan, Richard D. Gless, JR., Dinesh Patel, Gabor Rubanyi, Yi-Xin Wang, Heather K. Webb Hsu
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20090082423
    Abstract: Disclosed are amide, thioamide, urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.
    Type: Application
    Filed: September 10, 2008
    Publication date: March 26, 2009
    Inventors: Sampath-Kumar Anandan, Richard D. Gless, JR.
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20090082350
    Abstract: Disclosed are heterocylic or heteroaryl compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.
    Type: Application
    Filed: September 10, 2008
    Publication date: March 26, 2009
    Inventors: Sampath-Kumar Anandan, Richard D. Gless, JR.
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20090023731
    Abstract: Disclosed are urea and thiourea compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, and diabetic-related diseases.
    Type: Application
    Filed: March 21, 2008
    Publication date: January 22, 2009
    Inventors: Richard D. Gless, JR., Sampath Kumar Anandan
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20080227780
    Abstract: Disclosed are urea compounds, stereoisomer, or pharmaceutical acceptable salt thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.
    Type: Application
    Filed: October 19, 2007
    Publication date: September 18, 2008
    Inventors: Richard D. Gless, Sampath Kumar Anandan, Bhaskar R. Aavula
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20080221100
    Abstract: Disclosed are urea compounds, stereoisomer, or pharmaceutical acceptable salt thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.
    Type: Application
    Filed: October 19, 2007
    Publication date: September 11, 2008
    Inventors: Richard D. Gless, Sampath Kumar Anandan, Bhaskar R. Aavula
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20080200444
    Abstract: Disclosed are urea compounds of formula I, stereoisomer, or pharmaceutical acceptable salts thereof, and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.
    Type: Application
    Filed: October 19, 2007
    Publication date: August 21, 2008
    Inventors: Richard D. Gless, Sampath Kumar Anandan
  • SOLUBLE EPOXIDE HYDROLASE INHIBITORS
    Publication number: 20080200467
    Abstract: Disclosed are alpha keto amide and alpha hydroxy amide compounds and compositions that inhibit soluble epoxide hydrolase (sEH), methods for preparing the compounds and compositions, and methods for treating patients with such compounds and compositions. The compounds, compositions, and methods are useful for treating a variety of sEH mediated diseases, including hypertensive, cardiovascular, inflammatory, pulmonary, and diabetic-related diseases.
    Type: Application
    Filed: November 2, 2007
    Publication date: August 21, 2008
    Inventors: Dinesh Patel, Richard D. Gless, Heather K. Webb Hsu, Sampath Kumar Anandan, Bhaskar R. Aavula
  • Lincomycin derivatives possessing antimicrobial activity
    Patent number: 7199106
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: April 3, 2007
    Assignee: Vicuron Pharmaceuticals, Inc.
    Inventors: Jason G. Lewis, Sampath-Kumar Anandan, Hardwin O'Dowd, Mikhail F. Gordeev
  • Lincomycin derivatives possessing antibacterial activity
    Patent number: 7199105
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against bacteria, including gram positive organisms, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: April 3, 2007
    Assignee: Vicuron Pharmaceuticals, Inc.
    Inventors: Jason G. Lewis, Dinesh V. Patel, Sampath Kumar Anandan, Mikhail F. Gordeev
  • Novel lincomycin derivatives possessing antimicrobial activity
    Publication number: 20050043248
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. The compounds of the subject invention may exhibit potent activities against bacteria, including gram positive organisms, and may be useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Application
    Filed: June 17, 2004
    Publication date: February 24, 2005
    Inventors: Jason Lewis, Sampath-Kumar Anandan, Hardwin O'Dowd, Mikhail Gordeev
  • Lincomycin derivatives possessing antibacterial activity
    Publication number: 20040230046
    Abstract: Novel lincomycin derivatives are disclosed. These lincomycin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against bacteria, including gram positive organisms, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.
    Type: Application
    Filed: February 11, 2004
    Publication date: November 18, 2004
    Applicant: VICURON PHARMACEUTICALS INC.
    Inventors: Jason G. Lewis, Dinesh V. Patel, Sampath Kumar Anandan, Mikhail F. Gordeev